文献速递关节外科

髋膝关节置换术后慢性阿片类药物使用的风险因素:新西兰人群数据证据

Risk Factors for Chronic Opioid Use Following Hip and Knee Arthroplasty: Evidence from New Zealand Population Data.
PubMed 文献 · J Arthroplasty · 2020-06-27

该研究基于新西兰公共医疗系统全人群队列,识别全髋或全膝关节置换术后3年内慢性阿片类药物使用的风险因素。术前阿片类药物使用是最强风险因素,围手术期阿片类药物使用、酒精或药物滥用史、年轻、女性、膝关节置换、多种合并症及术前使用部分镇痛药亦为显著风险因素,而较高教育水平和术前使用非甾体抗炎药为保护因素。

要点

  • 术前阿片类药物使用是关节置换术后慢性阿片类药物使用的最强风险因素。
  • 其他显著风险因素包括围手术期阿片类药物使用、酒精或药物滥用史、年轻、女性、膝关节置换、多种合并症及术前使用部分镇痛药。
  • 较高教育水平和术前使用非甾体抗炎药为保护因素。

核心结论

  • 该研究基于全国性综合人群队列,随访3年,识别出若干可改变的风险因素及其他易于测量的患者特征与术后长期阿片类药物使用风险较高相关。

研究设计与样本

  • 从新西兰卫生部记录中识别所有在新西兰公共医疗系统接受全关节置换术的患者,构建综合人群队列。
  • 从关联的人群数据库中识别术后3年内阿片类药物配药情况及潜在风险因素,包括人口学、社会经济、手术相关特征、既往合并症及术前其他镇痛药物使用。
  • 采用逻辑回归分析识别与术后慢性阿片类药物使用相关的因素。

主要发现

  • 术后慢性阿片类药物使用的最强风险因素为术前阿片类药物使用。
  • 其他显著风险因素包括围手术期阿片类药物使用、酒精或药物滥用史、较年轻年龄、女性、膝关节置换、若干合并症及术前使用部分镇痛药物。
  • 保护因素包括较高教育水平和术前使用非甾体抗炎药。
  • 多数风险因素对术后慢性阿片类药物使用的效应在随访1年、2年或3年时相似。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients awaiting total joint arthroplasty (TJA) have high rates of opioid use, and many continue to use opioid medications long term after surgery. The objective of this study is to estimate the risk factors associated with chronic opioid use after TJA in a comprehensive population-based cohort. METHODS: All patients undergoing TJA in the New Zealand public healthcare system were identified from Ministry of Health records. Dispensing of opioid medications up to 3 years postsurgery and potential risk factors, including demographic, socioeconomic, and surgery-related characteristics, pre-existing medical comorbidities, and use of other analgesic medications prior to surgery, were identified from linked population databases. Logistic regression analysis was used to identify factors associated with chronic postoperative opioid use. RESULTS: The strongest risk factor for chronic postoperative opioid use was preoperative opioid use. Other significant risk factors included perioperative opioid use, history of alcohol or drug abuse, younger age, female gender, knee arthroplasty, several comorbid health conditions, and preoperative use of some analgesic medications. Protective factors included higher education levels and preoperative use of nonsteroidal anti-inflammatory drugs. Most risk factors had similar effects on chronic postoperative opioid use irrespective of the length of follow-up considered (1, 2, or 3 years). CONCLUSION: This study of a comprehensive nationwide population-based cohort of TJA patients with 3 years of follow-up identified several modifiable risk factors and other easily measured patient characteristics associated with higher risk of long-term postoperative opioid use.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Pryymachenko Y, Wilson RA, Abbott JH, et al. Risk Factors for Chronic Opioid Use Following Hip and Knee Arthroplasty: Evidence from New Zealand Population Data. J Arthroplasty. 2020. PMID: 32684397. doi:10.1016/j.arth.2020.06.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。